vs
DBV Technologies S.A.（DBVT）与Token Cat Ltd（TC）财务数据对比。点击上方公司名可切换其他公司
DBV Technologies S.A.的季度营收约是Token Cat Ltd的1.0倍（$2.8M vs $2.8M），Token Cat Ltd净利率更高（-3.4% vs -1195.5%，领先1192.2%），DBV Technologies S.A.同比增速更快（158.8% vs -37.9%）
DBV Technologies是一家总部位于法国巴涅的公开上市生物制药企业，核心研发成果为Viaskin给药技术，可在不进入血液循环的前提下，让过敏原或抗原作用于完整皮肤。其花生过敏疗法Viaskin Peanut的临床开发，已获得美国食品药品监督管理局授予快速通道资格。
DBVT vs TC — 直观对比
营收规模更大
DBVT
是对方的1.0倍
$2.8M
营收增速更快
DBVT
高出196.7%
-37.9%
净利率更高
TC
高出1192.2%
-1195.5%
损益表 — Q3 FY2025 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $2.8M | $2.8M |
| 净利润 | $-33.2M | $-93.0K |
| 毛利率 | — | 79.0% |
| 营业利润率 | -1235.7% | -206.9% |
| 净利率 | -1195.5% | -3.4% |
| 营收同比 | 158.8% | -37.9% |
| 净利润同比 | -8.9% | 98.3% |
| 每股收益（稀释后） | $-0.24 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DBVTTC
| Q3 25 | $2.8M | — | ||
| Q2 25 | $1.5M | $2.8M | ||
| Q2 24 | $1.2M | $4.4M | ||
| Q1 24 | $1.4M | — | ||
| Q4 23 | $8.9M | — | ||
| Q3 23 | $2.4M | — | ||
| Q2 23 | $2.3M | $12.7M | ||
| Q1 23 | $2.2M | — |
净利润DBVTTC
| Q3 25 | $-33.2M | — | ||
| Q2 25 | $-41.9M | $-93.0K | ||
| Q2 24 | $-33.1M | $-5.6M | ||
| Q1 24 | $-27.3M | — | ||
| Q4 23 | $134.3M | — | ||
| Q3 23 | $-16.7M | — | ||
| Q2 23 | $-24.2M | $-4.2M | ||
| Q1 23 | $-20.6M | — |
毛利率DBVTTC
| Q3 25 | — | — | ||
| Q2 25 | — | 79.0% | ||
| Q2 24 | — | 69.2% | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | 63.4% | ||
| Q1 23 | — | — |
营业利润率DBVTTC
| Q3 25 | -1235.7% | — | ||
| Q2 25 | -2806.2% | -206.9% | ||
| Q2 24 | -2914.9% | -146.9% | ||
| Q1 24 | -2029.7% | — | ||
| Q4 23 | -134.3% | — | ||
| Q3 23 | -770.2% | — | ||
| Q2 23 | -1096.0% | -59.9% | ||
| Q1 23 | -964.7% | — |
净利率DBVTTC
| Q3 25 | -1195.5% | — | ||
| Q2 25 | -2858.4% | -3.4% | ||
| Q2 24 | -2852.4% | -125.9% | ||
| Q1 24 | -1943.5% | — | ||
| Q4 23 | 1512.8% | — | ||
| Q3 23 | -705.6% | — | ||
| Q2 23 | -1059.6% | -33.3% | ||
| Q1 23 | -937.1% | — |
每股收益（稀释后）DBVTTC
| Q3 25 | $-0.24 | — | ||
| Q2 25 | $-0.31 | — | ||
| Q2 24 | $-0.34 | — | ||
| Q1 24 | $-0.28 | — | ||
| Q4 23 | $-0.11 | — | ||
| Q3 23 | $-0.17 | — | ||
| Q2 23 | $-0.26 | — | ||
| Q1 23 | $-0.22 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $69.8M | $150.0K |
| 总债务越低越好 | — | $1.4M |
| 股东权益账面价值 | $52.9M | $4.6M |
| 总资产 | $110.5M | $28.4M |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资DBVTTC
| Q3 25 | $69.8M | — | ||
| Q2 25 | $103.2M | $150.0K | ||
| Q2 24 | $66.2M | $689.0K | ||
| Q1 24 | $101.5M | — | ||
| Q4 23 | $141.4M | — | ||
| Q3 23 | $149.1M | — | ||
| Q2 23 | $174.0M | $3.0M | ||
| Q1 23 | $192.3M | — |
总债务DBVTTC
| Q3 25 | — | — | ||
| Q2 25 | — | $1.4M | ||
| Q2 24 | — | $1.8M | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
股东权益DBVTTC
| Q3 25 | $52.9M | — | ||
| Q2 25 | $86.2M | $4.6M | ||
| Q2 24 | $79.1M | $-787.0K | ||
| Q1 24 | $111.7M | — | ||
| Q4 23 | $140.2M | — | ||
| Q3 23 | $144.0M | — | ||
| Q2 23 | $164.2M | $9.1M | ||
| Q1 23 | $179.1M | — |
总资产DBVTTC
| Q3 25 | $110.5M | — | ||
| Q2 25 | $143.4M | $28.4M | ||
| Q2 24 | $114.2M | $12.5M | ||
| Q1 24 | $145.9M | — | ||
| Q4 23 | $183.0M | — | ||
| Q3 23 | $189.8M | — | ||
| Q2 23 | $217.5M | $25.1M | ||
| Q1 23 | $232.9M | — |
负债/权益比DBVTTC
| Q3 25 | — | — | ||
| Q2 25 | — | 0.30× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-32.4M | $-23.7M |
| 自由现金流经营现金流 - 资本支出 | $-32.6M | — |
| 自由现金流率自由现金流/营收 | -1173.5% | — |
| 资本支出强度资本支出/营收 | 4.2% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-138.3M | — |
8季度趋势，按日历期对齐
经营现金流DBVTTC
| Q3 25 | $-32.4M | — | ||
| Q2 25 | $-33.9M | $-23.7M | ||
| Q2 24 | $-35.1M | $-1.5M | ||
| Q1 24 | $-34.7M | — | ||
| Q4 23 | $-13.7M | — | ||
| Q3 23 | $-19.6M | — | ||
| Q2 23 | $-25.6M | $-7.2M | ||
| Q1 23 | $-20.8M | — |
自由现金流DBVTTC
| Q3 25 | $-32.6M | — | ||
| Q2 25 | $-33.9M | — | ||
| Q2 24 | $-35.8M | $-1.5M | ||
| Q1 24 | $-36.0M | — | ||
| Q4 23 | $-14.0M | — | ||
| Q3 23 | $-19.6M | — | ||
| Q2 23 | $-25.7M | — | ||
| Q1 23 | $-21.0M | — |
自由现金流率DBVTTC
| Q3 25 | -1173.5% | — | ||
| Q2 25 | -2316.5% | — | ||
| Q2 24 | -3084.0% | -34.4% | ||
| Q1 24 | -2560.6% | — | ||
| Q4 23 | -158.2% | — | ||
| Q3 23 | -827.3% | — | ||
| Q2 23 | -1124.0% | — | ||
| Q1 23 | -955.0% | — |
资本支出强度DBVTTC
| Q3 25 | 4.2% | — | ||
| Q2 25 | 2.2% | — | ||
| Q2 24 | 63.0% | 0.0% | ||
| Q1 24 | 94.9% | — | ||
| Q4 23 | 4.0% | — | ||
| Q3 23 | 2.1% | — | ||
| Q2 23 | 7.2% | — | ||
| Q1 23 | 5.1% | — |
现金转化率DBVTTC
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | -0.10× | — | ||
| Q3 23 | — | — | ||
| Q2 23 | — | — | ||
| Q1 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
